Molecular profiling of tumors has been shown to improve risk stratification, and it may be useful for prostate cancer active surveillance.
The patient and local surgical team were located in Gibraltar, about 2,400 kilometers (about 1,500 miles) away. The procedure ...
A pioneering feat of British medical innovation has seen a surgeon in London successfully remove a patient's prostate while the man lay on an operating table some 1,500 miles away in Gibraltar. Prof ...
A large national study in Denmark following nearly 1,900 patients over almost a decade has found that a minimally invasive ...
A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that ...
AUA Announces Updates to the Early Detection of Prostate Cancer Guideline Today, the American Urological Association (AUA), ...
Fernando Viera Reyes needed a biopsy for possible prostate cancer when the Trump administration sent him to an immigration ...
Feb. 12, 2026 8:30 AM ETProfound Medical Corp. (PROF), PRN:CA “We are deeply grateful to INOVAIT for supporting a vision where AI‑enabled, image‑guided therapies like TULSA-PRO are not only developed ...
TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage innovator in interventional MRI (“iMRI”) procedures, is ...
Prostate cancer burden in 2026 is high, with disproportionate incidence and mortality in Black men and major survival decrements in distant-stage disease, supporting equitable, stage-shifting ...